ClinicalTrials.Veeva

Menu
Novum Research, LLC | Clermont, FL logo

Novum Research, LLC | Clermont, FL

Research site

Site insights

Top conditions

Top treatments

SAR441566
Risankizumab
Vedolizumab
Mirikizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Jovani Rivera, Site Director

Verified by this site

Active trials

5 of 5 total trials

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severe...

Enrolling
Ulcerative Colitis Chronic
Ulcerative Colitis
Drug: Placebo
Drug: Eltrekibart

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the...

Enrolling
Crohn's Disease
Drug: Placebo for risankizumab
Drug: Risankizumab SC
Locations recently updated

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large...

Enrolling
Ulcerative Colitis
Drug: Risankizumab
Drug: Vedolizumab

This is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o...

Enrolling
Crohn's Disease
Drug: SAR441566
Drug: SAR441566 matching Placebo

This is a Phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety o...

Enrolling
Colitis Ulcerative
Drug: SAR441566 matching Placebo
Drug: SAR441566

Trial sponsors

AbbVie logo
Sanofi logo
Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems